A previous mass spectrometry analysis of ERG immunoprecipitated from prostate cancer cells with a TMPRSS2/ERG fusion, identified S215 phosphorylation [42], indicating that this modification can occur in vivo. Here, TMPRSS2 is linked to prostate cancer.